# A Study to Evaluate ID-085 in People With Mild, Moderate, and Severe Kidney Disease

> **NCT03913000** · PHASE1 · COMPLETED · sponsor: **Idorsia Pharmaceuticals Ltd.** · enrollment: 32 (actual)

## Conditions studied

- Renal Impairment

## Interventions

- **DRUG:** ID-085

## Key facts

- **NCT ID:** NCT03913000
- **Lead sponsor:** Idorsia Pharmaceuticals Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-29
- **Primary completion:** 2019-08-22
- **Final completion:** 2019-08-22
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2019-11-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03913000

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03913000, "A Study to Evaluate ID-085 in People With Mild, Moderate, and Severe Kidney Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03913000. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*